Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
761.190.04%
QQQ
709.620.06%
BTC/USD
78171.801.7864%
DIA
524.720.04%
GLD
393.130.07%
TLT
80.93-

Cullinan Therapeutics Inc (CGEM) Stock Price, Quote, News & History

CGEMNASDAQ
Trade with Public
Trade with Public
$20.40
-0.19-0.92%
At close: Sep 14, 5:00 PM EST
$20.40
N/A
After Hours: 4:00 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Cullinan Therapeutics (CGEM) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$18.55
Close
$20.40
Volume / Avg.
1.42M / 858.03K
Day Range
$18.51 - $20.93
52 Wk Range
5.68 - 23.19
Market Cap
$1.31B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
47
Short Interest
22.44%
Days to Cover
15.48

Recent Cullinan Therapeutics, Inc. News

Cullinan Therapeutics Zipalertinib Combo Clears Key Phase 3 Hurdle As First-Line Lung Cancer Treatment Option Takes Shape

Cullinan Therapeutics and Taiho report positive Phase 3 trial results for zipalertinib in treating advanced lung cancer.
Vandana Singh

Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in pre-market trading. The company recently announced a 1-for-20 reverse stock split.The shares of Marvell Technology Inc (NASDAQ: MRVL) surged in pre-market trading after securing a spot in the S&P 500 index, while Real Messenger Corp (NASDAQ: RMSG) experienced a significant decline. Other gainers in pre-market trading include Dreamland Ltd (NASDAQ: TDIC), Gamehaus Holdings Inc (NASDAQ: GMHS), Nurix Therapeutics Inc (NASDAQ: NRIX), SmartKem Inc (NASDAQ: SMTK), Mountain Lake Acquisition Corp (NASDAQ: MLAC), Battalion Oil Corp (NASDAQ: BATL), Qtrex Quantum Ltd (NASDAQ: QTEX), Bone Biologics Corp (NASDAQ: BBLG), and Cullinan Therapeutics Inc (NASDAQ: CGEM).
Avi Kapoor

Global Business Travel Group Posts Upbeat Q1 Results, Joins Cabaletta Bio, Aura Biosciences And Other Big Stocks Moving Higher On Monday

Global Business Travel Group Inc (GBTG), a NYSE-listed company, saw its stock rise 57% on Monday after reporting better-than-expected financial results. Other top gainers included companies like Cabaletta Bio Inc, Celcuity Inc, and Xerox Holdings Corp.
Avi Kapoor

Paramount Skydance, Wave Life Sciences, Ocular Therapeutix, Carvana And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Alibaba, Oscar Health, Ondas Holdings, Lumentum, Tesla And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-159.25M
Investing Cash Flow (TTM)
162.88M
Financing Cash Flow (TTM)
2.19M
Free Cash Flow (TTM)
-159.30M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
5.82M

Analyst Trends and Forecast

2
Jun
1
Jul
2
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$991.31M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
4.11
Earnings Yield % (TTM)
-15.12%
Earnings Yield % (FWD)
-15.41%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.00

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$78.64M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$18.55
Close
$20.40
Volume / Avg.
1.42M / 858.03K
Day Range
$18.51 - $20.93
52 Wk Range
5.68 - 23.19
Market Cap
$1.31B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
47
Short Interest
22.44%
Days to Cover
15.48

About

Sector
Health Care
Industry
Biotechnology
Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is b...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Cullinan Therapeutics (CGEM) stock?

A

You can purchase shares of Cullinan Therapeutics (NASDAQ:CGEM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cullinan Therapeutics (CGEM) competitors?

Q

What is the forecast, or price target, for Cullinan Therapeutics (CGEM) stock?

A

Cullinan Therapeutics has a consensus price target of $29.75.

Q

What is the current price for Cullinan Therapeutics (CGEM)?

A

The stock price for Cullinan Therapeutics (NASDAQ: CGEM) is $20.4 last updated September 14, 2026 at 4:00 PM EDT.

Q

Does Cullinan Therapeutics (CGEM) pay a dividend?

A

There are no upcoming dividends for Cullinan Therapeutics.

Q

When is Cullinan Therapeutics (NASDAQ:CGEM) reporting earnings?

A

Cullinan Therapeutics does not have any upcoming earnings scheduled.

Q

Is Cullinan Therapeutics (CGEM) going to split?

A

There is no upcoming split for Cullinan Therapeutics.

Q

What sector and industry does Cullinan Therapeutics (CGEM) operate in?

A

Cullinan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved